These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18551721)

  • 21. The effectiveness of prenatal serum biomarker screening for neural tube defects in second trimester pregnant women: a meta-analysis.
    Wang ZP; Li H; Hao LZ; Zhao ZT
    Prenat Diagn; 2009 Oct; 29(10):960-5. PubMed ID: 19609892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for open neural tube defects from 21 to 25 weeks' gestation: the Manitoba experience.
    Björklund NK; MacDonald KM; Evans JA; Schneider CE; Chodirker BN
    Prenat Diagn; 2005 Aug; 25(8):715-7. PubMed ID: 16052469
    [No Abstract]   [Full Text] [Related]  

  • 23. [Specificity of biochemical markers of pregnancy second trimester].
    Salazar López R; Ibarra Gallardo AL; Iduma Meléndrez M; Leyva Bojórquez R
    Ginecol Obstet Mex; 2007 Oct; 75(10):608-14. PubMed ID: 18800579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening model of studying alpha-foetoprotein of maternal serum (S-AFP) organized within central dispensary follow-up of pregnant women in Baranya region.
    Kóbor J; Pejtsik B; Pácsa S
    Sante Publique (Bucur); 1982; 25(3):193-9. PubMed ID: 6187074
    [No Abstract]   [Full Text] [Related]  

  • 25. The clinical significance of low maternal serum alpha-fetoprotein in obstetric practice.
    Sowers SG; Burton BK
    Birth Defects Orig Artic Ser; 1982; 18(3 Pt A):181-4. PubMed ID: 6181823
    [No Abstract]   [Full Text] [Related]  

  • 26. [A study on the relationship between elevated maternal serum fetoprotein and abnormal pregnancy in Taiyuan District].
    Zheng ZQ; Ma AY
    Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):106-8. PubMed ID: 6190541
    [No Abstract]   [Full Text] [Related]  

  • 27. Alpha-fetoprotein screening.
    Crandall BF
    West J Med; 1984 Jun; 140(6):931. PubMed ID: 6204461
    [No Abstract]   [Full Text] [Related]  

  • 28. Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound.
    Dashe JS; Twickler DM; Santos-Ramos R; McIntire DD; Ramus RM
    Am J Obstet Gynecol; 2006 Dec; 195(6):1623-8. PubMed ID: 16769022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Open neural tube defects in prenatal diagnosis].
    Zaremba J; Roszkowski T; Szirkowiec W
    Przegl Lek; 1998; 55(4):159-63. PubMed ID: 9656739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More on maternal serum alpha-fetoprotein: problems with a test kit.
    N Engl J Med; 1986 Jul; 315(3):193-5. PubMed ID: 2425258
    [No Abstract]   [Full Text] [Related]  

  • 31. Prenatal maternal serum screening during the second trimester of pregnancy using the Triple Test in Luxembourg.
    Thix J
    Bull Soc Sci Med Grand Duche Luxemb; 2006; (3):387-405. PubMed ID: 17209295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Women's attitudes toward the serum alpha-fetoprotein test.
    Dembert ML; Watson RE; Mick SS; Phillips R; Meyer J; Matzkin P; Harisiades JP; Mahoney MJ
    Conn Med; 1983 Sep; 47(9):525-9. PubMed ID: 6194933
    [No Abstract]   [Full Text] [Related]  

  • 33. Maternal serum alpha-fetoprotein screening.
    American Public Health Association
    Am J Public Health; 1991 Feb; 81(2):241-2. PubMed ID: 11642861
    [No Abstract]   [Full Text] [Related]  

  • 34. Alpha-fetoprotein and its relevance to human disease.
    Wepsic HT; Kirkpatrick A
    Gastroenterology; 1979 Oct; 77(4 Pt 1):787-96. PubMed ID: 89060
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of provider characteristics and insurance status on maternal serum alpha-fetoprotein screening.
    Jenkins-Woelk LD; Baldwin LM; Raine TR; Hart LG; Fordyce MA; Rosenblatt RA
    J Am Board Fam Pract; 1998; 11(5):357-65. PubMed ID: 9796765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits of maternal serum alpha-fetoprotein testing.
    Dyson RD
    Am Fam Physician; 1996 Nov; 54(6):1890, 1893. PubMed ID: 8900347
    [No Abstract]   [Full Text] [Related]  

  • 37. Maternal serum alpha-fetoprotein levels in fetal hydrocephalus: a retrospective population based study.
    Szajkowski TP; Chodirker BN; MacDonald KM; Evans JA
    BMC Pregnancy Childbirth; 2006 Jul; 6():23. PubMed ID: 16824231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
    Brossard P; Boulvain M; Coll O; Barlow P; Aebi-Popp K; Bischof P; Martinez de Tejada B; ;
    AIDS; 2008 Oct; 22(15):2013-7. PubMed ID: 18784463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-fetoprotein and AChE in early amniocentesis.
    Eiben B; Goebel R; Hansen S; Hammans W
    Prenat Diagn; 1996 Jan; 16(1):87-8. PubMed ID: 8821860
    [No Abstract]   [Full Text] [Related]  

  • 40. The psychological impact of false positive elevations of maternal serum alpha-fetoprotein.
    Burton BK; Dillard RG; Clark EN
    Am J Obstet Gynecol; 1985 Jan; 151(1):77-82. PubMed ID: 2578251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.